PRE 14A

PRELIMINARY PROXY STATEMENT

Company: ABVC BIOPHARMA, INC.
Filed: May 31, 2023
Period of Report: May 31, 2023
Accession Number: 0001213900-23-044411

View Document ↗ View on SEC.gov ↗